Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Portugal and Spain or involving organisations from these countries.

Total search results: 200 | Ordered by Date (descending)
1 2 3  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Mestrelab Research–SpectralWorks: analytical instrument software, 201708– collab mutual reseller agreem for all respective NMR/MS s/w products 2017-08-15
Evosciences–Danaher: mass spectrometer, 201707– distribution of Sciex MS systems with flexible finacing packages via Evosciences in Europe 2017-07-27
GigaGen–Grifols: investment, acquisition of 44% stake in GigaGen Inc for $35m in cash by Grifols 2017-07-05
FB Health–Invent Farma/Neuraxpharm: investment, 201706 acquisition €na of FB Health by Invent Farma/Neuraxpharm (formed 8/16 by Apax Partners) 2017-06-21
Oryzon Genomics–JMP Securities: investor conference, 201706 supply service Oryzon at JMP Securities 2017 Life Sciences Conference NY 2017-06-20
Medicxi Ventures–Alphabet: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–EU (govt): investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–Novartis: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–SEVERAL: investment, 201706 closing $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Oryzon Genomics–Leucadia: investor conference, 201706 supply service Oryzon presents at Jefferies Healthcare Conference in New York 2017-06-09
Oryzon Genomics–Trout Group: public relations, 201705 service existent investor relations by Trout Group 2017-05-31
AptaTargets–Inveready: investment, 201705 financing round totalling €2.7m from Caixa Capital Risc + Inveready 2017-05-17
AptaTargets–la Caixa: investment, 201705 financing round totalling €2.7m from Caixa Capital Risc + Inveready 2017-05-17
AptaTargets–SEVERAL: investment, 201705 financing round €2.7m from Caixa Capital Risc + Inveready 2017-05-17
Specialised Therapeutics Australia–PharmaMar: lurbinectedin, 201705– license to market lurbinectedin in AU + NZ + 12 Asian countries for STA 2017-05-17
Genetrix (ES)–SEVERAL: investment, 201705– capital increase up to €10m w rights offering + private placement Sygnis AG 2017-05-08
Innova Biosciences–Genetrix (ES): investment, 201705–201707 acquisition €8m cash + 2m Sygnis shares plus up to 1.5m shares by Sygnis AG 2017-05-08
Celyad–Deutsche Bank: investor conference, 201705 supply service Celyad presents at Deutsche Bank Annual Health Care Conference 2017-05-04
Vivet Therapeutics–Columbus Venture Partners: investment, 201705 financing round Series A totalling €37.5m incl co-lead investor CVP 2017-05-04
Vivet Therapeutics–Huntsworth: public relations, 201705 service existent by Citigate Dewe Rogerson 2017-05-04
Vivet Therapeutics–Kurma: investment, 201705 financing round Series A totalling €37.5m incl co-investor Kurma Partners 2017-05-04
Vivet Therapeutics–Novartis: investment, 201705 financing round Series A totalling €37.5m incl co-lead investor Novartis Venture Fund 2017-05-04
Vivet Therapeutics–Odlander Fredrikson: investment, 201705 financing round Series A totalling €37.5m incl co-investor HealthCap 2017-05-04
Vivet Therapeutics–Roche: investment, 201705 financing round Series A totalling €37.5m incl co-investor Roche Venture Fund 2017-05-04
Vivet Therapeutics–SEVERAL: investment, 201705 financing round Series A €37.5m led by Novartis Venture Fund + Columbus Venture Partners 2017-05-04
Vivet Therapeutics–Ysios Capital: investment, 201705 financing round Series A totalling €37.5m incl co-investor Ysios Capital 2017-05-04
EMBL–Enamine: chemical compound library, 201704– collab library synthesis + medical chemistry + biological services for cancer drug research 2017-04-25
Oryzon Genomics–SEVERAL: investment, 201703 private placement €18.2m w 5.7m news common shares at €3.2/share 2017-03-31
Versantis–SEVERAL: investment, 201703 financing round Series A CHF4.4m led by Redalpine Venture Partners 2017-03-29
BioClin Therapeutics–Life Sciences Partners: investment, 201703 financing round Series B totalling $30m incl existing investor LSP 2017-03-22
BioClin Therapeutics–Odlander Fredrikson: investment, 201703 financing round Series B totalling $30m incl existing investor HealthCap 2017-03-22
BioClin Therapeutics–SEVERAL: investment, 201703 financing round Series B $30m led by new investors Sofinnova Ventures + Ysios Capital 2017-03-22
BioClin Therapeutics–Sofinnova: investment, 201703 financing round Series B totalling $30m led by new investors Sofinnova Ventures + Ysios Capital 2017-03-22
BioClin Therapeutics–Tekla Capital: investment, 201703 financing round Series B totalling $30m incl existing investor Tekla Capital Management 2017-03-22
BioClin Therapeutics–Ysios Capital: investment, 201703 financing round Series B totalling $30m led by new investors Sofinnova Ventures + Ysios Capital 2017-03-22
Imegen (ES)–SEVERAL: investment, 201703 acquisition €10m of majority share in Imegen by Q-Growth Fund + Biolty 2017-03-16
Prexton Therapeutics–Forbion: investment, 201702 financing round Series B totalling €29m co-led by new investors Forbion + Seroba 2017-02-07
Prexton Therapeutics–Merck (DE): investment, 201702 financing round Series B totalling €29m incl returning co-investor Merck Ventures 2017-02-07
Prexton Therapeutics–Seroba: investment, 201702 financing round Series B totalling €29m co-led by new investors Forbion + Seroba 2017-02-07
Prexton Therapeutics–SEVERAL: investment, 201702 financing round Series B €29m co-led by new investors Forbion + Seroba 2017-02-07
Prexton Therapeutics–Sunstone Capital: investment, 201702 financing round Series B totalling €29m incl returning co-investor Sunstone Capital 2017-02-07
Prexton Therapeutics–Ysios Capital: investment, 201702 financing round Series B totalling €29m incl returning co-investor Ysios Capital 2017-02-07
Villapharma Research–Eurofins: investment, 201612– acquisition of Villapharma by Eurofins ANNOUNCED 2016-12-29
C.B.S. Scientific–Genetrix (ES): investment, 201612 acquisition $900k of C.B.S. Scientific Company for $540k cash + $360k in shares by Sygnis AG 2016-12-21
Hologic–Grifols: investment, 201612 agreem for Grifols to acquire Hologic’s interest in joint NAT donor screening business for $1.85b 2016-12-14
EURE-CART project–EU (govt): grant, 201612c– Horizon 2020 grant €5.9m 4y for clinical research on CART T-cell immunotherapy 2016-12-12
MolMed–EU (govt): grant, 201612c– Horizon 2020 grant €2m for MolMed for 4y as coordinator of EURE-CART project 2016-12-12
Biopremier (PT)–SGS: investment, 201612 acquisition of 70% stake by SGS 2016-12-09
Genetrix (ES)–GBC: investor conference, 201612 supply service Sygnis AG presents at MKK Münchner Kapitalmarkt Konferenz 2016 2016-12-07
OxThera–SEVERAL: investment, 201611 financing round €32m co-led by Life Sciences Partners + Ysios Capital + Sunstone Capital + Flerie Invest 2016-11-29
Neovacs–Infarco: biologics contract manufacturing, 201611– supply of IFNalpha by 3P Biopharmaceuticals to Neovacs 2016-11-23
Genetrix (ES)–Deutsche Börse: investor conference, 201611 supply service Sygnis AG presents at Deutsches Eigenkapitalforum 2016 2016-11-21
CorWave–SEVERAL: investment, 2013 financing round Series A 2016-11-04
CorWave–SEVERAL: investment, 201611 financing round Series B €15.5m led by new investor Novo Seeds 2016-11-04
Iproteos–SEVERAL: investment, 201610 financing round €1.5m led by Caixa Capital Risc + co-investors Kinled Holding + Ascil Biopharm 2016-10-25
Aura Biosciences–Ysios Capital: investment, 201610 existent investment of Ysios BioFund II Innverite FCR 2016-10-18
Megalab (ES)–Eurofins: investment, 201609 acquisition €40m of Megalab SA by Eurofins 2016-09-30
Oryzon Genomics–SEVERAL: credit, 201610 long-term loans €5.3m from Spanish commerical banks at current interest rates 2016-09-26
Oryzon Genomics–Informa: partnering conference, 201611 supply service Oryzon Presents at BioPharm America 2016 in Boston 2016-09-13
Oryzon Genomics–Rodman & Renshaw: investor conference, 201609 supply service Oryzon presents at Rodman & Renshaw Global Investment Conference in NY 2016-09-11
Oncovision–Bruker Corp: investment, 201609 acquisition €na of preclinical imaging business of Oncovision by Bruker 2016-09-07
DiViNe project–Affilogic: vaccine purification technology, 201609 collab Affilogic is partner in Horizon 2020 project led by iBET 2016-09-01
DiViNe project–Aquaporin: vaccine purification technology, 201609 collab Aquaporin is partner in Horizon 2020 project led by iBET 2016-09-01
DiViNe project–EU (govt): grant, 201609c– Horizon 2020 grant 5y to advance vaccine purification led by iBET 2016-09-01
DiViNe project–GSK: vaccine purification technology, 201609 collab GSK Italy is partner in Horizon 2020 project led by iBET 2016-09-01
DiViNe project–iBET (PT): vaccine purification technology, 201609 collab GenIbet + iBET are partners in Horizon 2020 project led by iBET 2016-09-01
DiViNe project–Merck (DE): vaccine purification technology, 201609– collab Merck is partner in Horizon 2020 project led by iBET 2016-09-01
Thomson Reuters–Onex Corp: investment, 201607–201610 acquisition $3.55b in cash of Thomson Reuters IP + Science business by Onex + Baring PE Asia 2016-07-11
Nicox–GHO Capital: investment, 201607– acquisition €26m with €9m cash + €12m shares+loan notes + €5m milestones of Nicox commercial operations by GHO 2016-07-05
MetaSUB project–Qiagen: genomic sample preparation, 201606– collab project using Qiagen sample tech + library prepration workflows 2016-06-21
Expedeon–Genetrix (ES): investment, 201605–201608 acquisition of Expedeon Holdings Ltd by Sygnis AG for €1.7m cash + na shares 2016-05-09
Genetrix (ES)–SEVERAL: investment, 201605–201607 capital increase Sygnis AG €5.3m w 3m rights offering + 1.8m shares private placement €1.1/share 2016-05-09
Oryzon Genomics–SEVERAL: credit, 201605 long-term loans €10.5m from Spanish commerical banks at current interest rates 2016-05-04
Peptomyc–SEVERAL: investment, 201604 seed financing round €1m led by HealthEquity 2016-04-27
STAT-Diagnostica–Boehringer: investment, 201604 financing round Series C totalling €25m incl returning co-investor BIVF 2016-04-11
STAT-Diagnostica–Gilde Investment: investment, 201604 financing round Series C totalling €25m incl led + new investor Gilde Healthcare 2016-04-11
STAT-Diagnostica–SEVERAL: investment, 201604 financing round Series C €25m led by new investor Gilde Healthcare 2016-04-11
Interstate Blood Bank–Grifols: investment, 201604 acquisition of 49% share for $100m plus $10m option to acquire remaining shares for $100m 2016-04-01
Progenika–Grifols: investment, 2016Q1 acquisition €25m of additional 32.9% bringing total Grifols shareholding to 89.1% 2016-03-31
Almirall–Grünenthal: investment, 201603– acquisition 100% of Almirall de Mexico SA de CV by Grünenthal ANNNOUNCED 2016-03-15
IDP Pharma–SEVERAL: investment, 201602 2nd financing round €1.4m 2016-02-01
GoodGut (ES)–SEVERAL: credit, 201601 loans €300k each €150k from La Caixa VC program + AGAUR/IFEM program 2016-01-27
GoodGut (ES)–SEVERAL: investment, 201601 2nd financing round €315k from Girona BAGI business angels + other private investors 2016-01-27
Aelix Therapeutics–JnJ: investment, 201601 financing round Series A totalling €11.5m incl co-investor JJDC 2016-01-11
Aelix Therapeutics–la Caixa: investment, 201601 financing round Series A totalling €11.5m incl co-investor Caixa Capital Risc 2016-01-11
Aelix Therapeutics–SEVERAL: investment, 201601 financing round Series A €11.5m led by Ysios Capital + incl JJDC + Caixa Capital Risc 2016-01-11
Aelix Therapeutics–Ysios Capital: investment, 201601 financing round Series A totalling €11.5m incl lead investor Ysios Capital 2016-01-11
Oryzon Genomics–SEVERAL: investment, 201512 listing on Madrid Stock Exchange at €3.39/share 2015-12-14
Genetrix (ES)–SEVERAL: investment, 201512 rights offering + private placement of Sygnis AG €5.6m with 2.963m new shares €1.9/share 2015-12-10
Lucigen–Genetrix (ES): genomic reagents, 201512– distribution of Sygnis TruePrime + SunScript RT products for clinical oncology research in US 2015-12-03
Mayflower Bioscience–Genetrix (ES): genomic reagents, 201512– distribution of Sygnis TruePrime + SunScript RT products in US 2015-12-02
Poli Group–Almirall: investment, 201511– acquisition 100% of Poli Group Holding by Almirall ANNOUNCED 2015-11-30
Genetrix (ES)–Deutsche Börse: investor conference, 201511 supply service Sygnis AG presents at Deutsches Eigenkapitalforum 2015 2015-11-23
Zeltia–PharmaMar: investment, 201511 reverse merger with new company trading as PharmaMar at MSE 2015-11-02
BioLamina–Cevec: rec protein production technology, 201510– license €na to CAP Go technology for laminins for ex vivo cell culture therapies 2015-10-28
Cevec–iBET (PT): rec protein production, 201510 collab existent GenIbet is joint venture partner of Cevec 2015-10-28
Grifols–EU (govt): credit, 201510–202510 loan €100m from European Investment Bank 2015-10-28
Oryzon Genomics–PERSON: investment, 201510 private placement totalling $19m incl new investor Joseph Fernandez acquiring 1% shareholding 2015-10-27
Oryzon Genomics–SEVERAL: investment, 201510 private placement €16.61m w 4.9m news shares at €3.39/share led by Bank Solventis AV 2015-10-27
Novartis–Palobiofarma: cancer drug, 201510– license developm + commercialisation of adenosine receptor agonist PBF-509 2015-10-21
1 2 3  next pagenext page



Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px